Previous Article | Next Article ![]()
Journal of Bacteriology, December 2001, p. 7165-7172, Vol. 183, No. 24
Area of Microbiology, Faculty of Biology and
Environmental Sciences, University of
León,1 and Institute of
Biotechnology of León, INBIOTEC, Science Park of
León,2 León, Spain
Received 5 July 2001/Accepted 14 September 2001
Pipecolic acid is a component of several secondary metabolites in
plants and fungi. This compound is useful as a precursor of
nonribosomal peptides with novel pharmacological activities. In
Penicillium chrysogenum pipecolic acid is converted into
lysine and complements the lysine requirement of three different lysine auxotrophs with mutations in the lys1,
lys2, or lys3 genes allowing a slow
growth of these auxotrophs. We have isolated two P.
chrysogenum mutants, named 7.2 and 10.25, that are unable to
convert pipecolic acid into lysine. These mutants lacked, respectively,
the pipecolate oxidase that converts pipecolic acid into
piperideine-6-carboxylic acid and the saccharopine reductase that
catalyzes the transformation of piperideine-6-carboxylic acid into
saccharopine. The 10.25 mutant was unable to grow in Czapek medium
supplemented with Many secondary metabolites contain
L-lysine, D-lysine, or pipecolic acid moieties
(29, 36). In filamentous fungi, the biosynthesis of
pipecolic acid is related to lysine metabolism. In Metarhizium
anisopliae and Rhizoctonia leguminicola pipecolic acid
is an intermediate in the biosynthesis of alkaloid compounds, such as
swansonine and slaframine. In these fungi pipecolic acid is formed by
catabolism of lysine (40-42). However, using
14C- and 15N-labeled
In Penicillium chrysogenum the biosynthetic pathway of
lysine and penicillin have several steps in common (reviewed in
references 1 and 12) (Fig.
1).
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.24.7165-7172.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Conversion of Pipecolic Acid into Lysine in Penicillium
chrysogenum Requires Pipecolate Oxidase and Saccharopine
Reductase: Characterization of the lys7 Gene
Encoding Saccharopine Reductase
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-aminoadipic acid. A DNA fragment complementing
the 10.25 mutation has been cloned; sequence analysis of the cloned
gene (named lys7) revealed that it encoded a protein
with high similarity to the saccharopine reductase from
Neurospora crassa, Magnaporthe grisea,
Saccharomyces cerevisiae, and Schizosaccharomyces
pombe. Complementation of the 10.25 mutant with the cloned gene
restored saccharopine reductase activity, confirming that
lys7 encodes a functional saccharopine reductase. Our
data suggest that in P. chrysogenum the conversion of
pipecolic acid into lysine proceeds through the transformation of
pipecolic acid into piperideine-6-carboxylic acid, saccharopine, and
lysine by the consecutive action of pipecolate oxidase, saccharopine reductase, and saccharopine dehydrogenase.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-aminoadipic acid and [14C]lysine, Aspen and
Meister (2) showed in Aspergillus nidulans that
the carbon chain of
-aminoadipic rather than that of lysine was the
major precursor of pipecolic acid and the nitrogen atom of
-aminoadipic acid becomes the nitrogen atom of pipecolic acid. Furthermore, in Neurospora crassa kinetic studies with
radioactively labeled D-lysine showed that
pipecolic acid was an intermediate in the conversion of
D-lysine into L-lysine
(17).
-Aminoadipic acid is the
intermediate where both branching routes diverge (11).
-Aminoadipic acid has a key function in penicillin biosynthesis,
since addition of exogenous
-aminoadipic acid (21) or
genetic modifications that increase the internal
-aminoadipic
acid pool (11, 22, 23) lead to a stimulation of the rate
of penicillin biosynthesis.
-Aminoadipic acid is converted into
piperideine-6-carboxylic acid (P6C) by
-aminoadipate reductase
(9), and the piperideine-6-carboxylate may be reduced to
pipecolic acid.

View larger version (21K):
[in a new window]
FIG. 1.
Biosynthesis of lysine and penicillin G in P.
chrysogenum showing the interconversion of pipecolic acid into
lysine. lys2 and lys5 encode two
different proteins required for
-aminoadipic acid reductase activity
(Lys5 is the cognate phosphopantetheinyl transferase that introduces a
phospantetheine group in Lys2). The conversion steps blocked in the 7.2 and 10.25 mutants are indicated by arrows with hatch marks through the
stems.
Pipecolic acid serves as a substrate of some nonribosomal peptide and
polyketide synthetases, resulting in the formation of secondary
metabolites with interesting novel pharmacological activities, i.e.,
the immunosuppressors rapamycin and immunomycin (31, 36). It seems, therefore, possible to use P. chrysogenum as a
host for producing pipecolate-containing secondary metabolites. Because of the ability of P. chrysogenum to accumulate
-aminoadipic acid, it was of interest to study the interconversion
of lysine and pipecolic acid in this industrially important filamentous fungus.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains.
Four different P. chrysogenum strains
were used in this work: P. chrysogenum Wisconsin 54-1255, a
low-level penicillin-producing strain that has a single copy of the
penicillin gene cluster (18); P. chrysogenum
HS1
, a lysine auxotroph disrupted in the
lys1 gene (5a); P. chrysogenum TDX195, a lysine auxotroph with the lys2 gene disrupted
(11); and P. chrysogenum L2, a lysine auxotroph
blocked in the first half of the
-aminoadipate pathway (16,
27a). Escherichia coli DH5
was used as host for
DNA plasmid manipulation. E. coli DH10B was used to recover
plasmids from the genomic DNA of P. chrysogenum.
Plasmid vector and plasmid genomic library. pAMPF9L (19) is a shuttle plasmid between E. coli and P. chrysogenum; it contains the AMA1 region, which confers autonomous replication in P. chrysogenum, and pBluescript for replication in E. coli. pLARA is an autonomous replication derivative of the pAMPF9L bearing the lys1 gene under the control of its own promoter region (3, 4). The genomic library was constructed by ligating partially digested Sau3AI genomic DNA obtained from P. chrysogenum AS-P-78 at the BglII site of the pAMPF9L plasmid.
Isolation of P. chrysogenum genomic DNA and
plasmid rescue in E. coli.
The genomic DNA of
P. chrysogenum was obtained as described previously
(10). For plasmid rescue, genomic DNA (1 µg of each transformant) was used to electroporate electrocompetent E. coli DH10B cells (39) in Bio-Rad Gene Pulser cuvettes
(0.2-cm gap). Electroporation conditions were 100
, 2,500 V, and 25 µF.
Mutant isolation.
P. chrysogenum
HS1
(a strain defective in the homocitrate
synthase) spores (106/ml) were incubated in 0.1 M
Tris-maleate buffer, pH 9.0, for 12 to 15 h. To induce synchronous
spore germination, which correlates with DNA synthesis
(28), 1.75 mM lysine, glucose (15 g/liter), and
(NH4)2SO4
(1 g/liter) were added to the spore suspension. The mutation was
carried out during 90 min with 0.5 mM nitrosoguanidine in the same
Tris-maleate buffer, pH 9.0, to obtain a mortality rate of 90%. Serial
dilutions of mutated spores were plated in Power medium plus lysine
(1.75 mM). Lysine auxotrophs unable to grow on pipecolic acid
(lys
pip
) were screened by replicating
each colony in Czapek minimal medium with pipecolic acid (100 mM) and
Czapek minimal medium without pipecolic acid. Reversion rates of the
mutations were determined for all the mutants by plating spore
suspensions (with known viable spore concentrations) on Czapek minimal
medium or Czapek medium plus pipecolic acid and counting the revertant colonies.
Enzyme activities.
Cultures of the different P. chrysogenum mutants were grown in defined production (DP) medium
(11). Cell extracts were prepared by grinding frozen
mycelium samples in a mortar. Disrupted cells (0.5 to 1 g) were
mixed with 1 ml of a solution containing 20 mM Tris-HCl (pH
8.0), 1 mM phenylmethylsulfonyl fluoride, 10 mM
-mercaptoethanol,
and 5 mM EDTA or 50 mM Tris-HCl-5 mM EDTA (pH 7.5) and centrifuged for
15 min at 4°C and 10,000 × g and the clarified
supernatant was collected. Protein concentration was determined by the
Bradford assay (7).
-ketoglutarate, and 50 µg of
total protein in 250 mM Tris-HCl (pH 7.5). Controls were performed
similarly but without lysine in the reaction mixture. Enzymatic
activity was expressed in units (1 U = 1 µmol of NADH consumed/min · ml; molar extinction [
] = 6,220 liters/mol · cm at 340 nm).
Saccharopine reductase (EC 1.5.1.10) activity was determined by
measuring P6C formation in the presence of 4 mM saccharopine, 0.5 mM
NADP, and 50 µg of total protein in 100 mM Tris-HCl (pH 9.0). Control
reactions were made without NADP in the reaction mixture. Enzyme assays
were performed for 1 h at 30°C and terminated by addition of 200 µl of 5% tricarboxylic acid (in ethanol). P6C was quantified by
derivatization of 500 µl of reaction mixture with 750 µl of
ortho-amino-benzaldehyde (OAB) (1 mg/ml in 2% ethanol) and
incubated for 30 min at 37°C, and the absorbance at 465 nm was
determined. The activity was expressed as units (1 U = 1 µmol of
P6C formed/min · ml; molar extinction of P6C-OAB [
] = 2,800 liters/mol · cm).
Pipecolic acid oxidase activity was quantified as described by
Mihalik et al. (30). The reaction mixture contained 10 mM L-pipecolic acid, 0.64 mM o-dianisidine, 20 U of
horseradish peroxidase, and 100 µg of total protein in buffer A (40 mM Tris-HCl, pH 8.5; 80 mM KCl; 0.8 mM EDTA). Blank controls lacked
L-pipecolic acid. The assay was performed for 15 min at 37°C, and H2O2
formation was determined by measuring the oxidized
o-dianisidine at 460 nm. The pipecolate oxidase activity was
expressed as units (1 U =1 µmol of o-dianisidine
oxidized/min · ml; molar extinction of the
o-dianisidine = 11,300 liter/mol · cm).
Transformation of P. chrysogenum and DNA sequencing. The transformation of P. chrysogenum protoplasts was performed as described previously (8). Transformants were selected in Czapek medium with 0.7 M KCl. DNA fragments were sequenced by the dideoxynucleotide chain termination method (38) using Sequenase (U.S. Biochemicals) in an ALF DNA sequencer (Pharmacia). All other nucleic acid manipulations were performed by using standard methods (37).
Total RNA isolation and intron analysis. Total RNA was isolated with the RNeasy kit (Qiagen, Chatsworth, Calif.) from P. chrysogenum Wis 54-1255 grown in DP medium (11). To elucidate the presence of putative introns in the DNA sequence, the region containing the expected intron splicing sites was amplified from RNA with a SuperScript one-step RT-PCR system (Gibco), using as primers the following oligonucleotides: Ia (5'-TGCGATGTTCTCCAGTTG-3') and Ib (5'-CGCATATACATCCCATTG-3').
Nucleotide sequence accession number. The lys7 nucleotide sequence has been deposited in the EMBL database under the accession number AJ319030.
| |
RESULTS |
|---|
|
|
|---|
Pipecolic acid is converted into lysine in P.
chrysogenum.
As a first approach to study the relationship
between pipecolic acid and lysine metabolism in P. chrysogenum, we tested if pipecolic acid could be converted into
lysine. Three P. chrysogenum lysine auxotrophic mutants
blocked (i) in the synthesis of
-aminoadipic, including P. chrysogenum HS1
(with a targeted
inactivation of the homocitrate synthase) and P. chrysogenum
L2 (defective in the homoaconitase) or (ii) in the conversion of
-aminoadipic acid to
-aminoadipic semialdehyde, e.g., P. chrysogenum TDX195 (disrupted in the lys2 gene encoding
-aminoadipate reductase), were tested for their ability to grow in
Czapek minimal medium supplemented with pipecolic acid. Results showed
(Fig. 2) that all three different lysine
auxotrophs were able to grow either with lysine or with pipecolic acid
although growth on pipecolic acid was very slow, indicating that in
P. chrysogenum, pipecolic acid is converted into lysine.
|
Isolation of lys
pip
mutants.
In order to study how
pipecolic acid is converted into lysine, mutants impaired in the
conversion of pipecolic acid into lysine were isolated from P. chrysogenum HS1
. These mutants should be
altered in any of the enzymes leading to lysine formation from
pipecolic acid.
phenotype) after screening 5,000 colonies following mutation with nitrosoguanidine. Analysis of the
reversion rate (Table 1) showed that
mutants 7.2 and 10.25 were stable whereas mutant 8.46 was highly
unstable. The first two mutants were used for further characterization
studies.
|
Mutant P. chrysogenum 10.25 is altered in the second
half of the lysine pathway.
To study whether pipecolic acid is
converted directly into lysine or whether it is transformed in some
intermediate of the lysine biosynthesis pathway, the isolated mutants
were plated in Czapek medium plus
-aminoadipic acid to test if they
have a functional conversion of
-aminoadipic acid into lysine.
Results showed (Table 1) that mutant 10.25 was unable to grow in Czapek medium plus
-aminoadipic acid, indicating that the mutation of this
strain alters one of the enzymes of the second half of the lysine
biosynthetic pathway (i.e., the
-aminoadipate reductase, saccharopine reductase, or saccharopine dehydrogenase). The conversion of pipecolic acid into lysine proceeds, therefore, through the action
of some of these enzymes. On the other hand mutant 7.2 was able to grow
on
-aminoadipic acid (see below).
Cloning of the lys7 gene by complementation of the
10.25 mutant.
In order to further characterize the conversion of
pipecolic acid into lysine, the gene complementing the mutation of the 10.25 strain was cloned. This mutant derives from the P. chrysogenum HS1
strain that has the
lys1 gene disrupted. For this reason, to clone the gene
responsible for the pip
phenotype a
cotransformation was performed with pLARA (autonomous replicating
plasmid bearing the lys1 gene) (4) and with a
genomic library constructed in the pAMPF9L (a vector bearing the AMA1 region which confers autonomous replication in P. chrysogenum) (19). After cotransformation of the
10.25 mutant, two transformants (named T1 and T2) were selected
directly in minimal Czapek medium. These transformants were
prototrophs, indicating that the lys1 mutation was
complemented; in addition they were able to convert pipecolic acid into lysine.
Rescue of the plasmids complementing the 10.25 mutant.
The
plasmids present in the T1 and T2 transformants were rescued in
E. coli. Analysis of the plasmid population present
in these E. coli transformants showed that some of them
(Fig. 3A, lanes 2, 3, 4, 5, 7, 11, and
15) were identical to the pLARA plasmid (Fig. 3, lane 1) whereas others
contained DNA inserts that might correspond to the lys7
gene or to DNA fragments that have recombined. To identify which of
these plasmids were recombinants bearing lys1 or
plasmids with inserts from the genomic library, Southern blotting was
performed with the lys1 gene as probe. Results (Fig. 3B)
showed that most plasmids present in the blot, except those in lanes
18, 19, and 20, gave hybridization with the lys1 gene. The nonhybridizing plasmids should contain the DNA fragment
complementing the pip
mutation. One of
these plasmids (Fig. 3, lanes 18 to 20) was named p10T1.
|
Cotransformation of the 10.25 mutant with pLARA and p10T1 indicates
that p10T1 contains the pip
-complementing
gene.
To test whether plasmid p10T1 was responsible for the
complementation of the pip
mutation, a
cotransformation of the 10.25 mutant was performed with the pLARA and
p10T1 plasmids. A large number of positive transformants were obtained.
Rescue of the plasmids from three transformants resulted in the
recovery of plasmids pLARA and p10T1 (Fig.
4), showing that both plasmids were
necessary to complement the double mutation
(lys1
and
pip
) in the 10.25 strain.
|
ORF1 of the cloned DNA fragment encodes a protein with high homology to saccharopine reductases. A 2,987-bp region of the insert of the p10T1 plasmid was sequenced on both strands. An open reading frame (ORF) of 1,953 bp (ORF1) was found. ORF1 contains 10 putative introns of 104, 62, 53, 50, 52, 59, 52, 55, 53, and 63 nucleotides. RT-PCR using RNA from 24-h cultures of P. chrysogenum Wis 54-1255 and oligonucleotides Ia and Ib as primers confirmed the presence of the 10 introns. A DNA band of the expected size after the splicing of the 10 introns (1,350 bp) was obtained. The amplified DNA band was sequenced on both strands, confirming that the introns had been removed at the splicing sites corresponding to nucleotides 53 to 156, 211 to 272, 455 to 507, 629 to 678, 752 to 803, 847 to 905, 920 to 971, 1019 to 1073, 1178 to 1230, and 1795 to 1857 (numbered from the ATG translation initiation codon).
ORF1 encoded a protein of 449 amino acids starting with a methionine encoded by an in-frame ATG with a deduced molecular mass of 48.8 kDa. No other ATG that might correspond to putative translation initiation codons was found in that region. The encoded protein showed a high similarity to other saccharopine reductases (Fig. 5), particularly those of N. crassa (70.4% identical amino acids), Magnaporthe grisea (66.6% identity) (24), Saccharomyces cerevisiae (63.1% identity) (6), and Schizosaccharomyces pombe (60% identity). The amino-terminal region of the encoded protein was very similar to that of the corresponding proteins of N. crassa, M. grisea, and S. cerevisiae. These results suggest that the protein encoded by ORF1 corresponds to the P. chrysogenum saccharopine reductase, and the gene has been named lys7, according to the gene designation in Fig. 1.
|
Pipecolic acid is converted into lysine by the action of the
saccharopine reductase and saccharopine dehydrogenase in the lysine
biosynthetic pathway.
To further characterize the
pip
mutants we measured the saccharopine
reductase and saccharopine dehydrogenase activities, which are involved
in the conversion of
-aminoadipic acid-
-semialdehyde into
saccharopine and then into lysine, respectively. Results showed (Table
2) that saccharopine dehydrogenase was
present in all strains studied. Mutant 10.25 lacked saccharopine
reductase, in agreement with the DNA cloning experiments that indicated
that the lys7 gene encodes a saccharopine reductase. These
results confirmed that the 10.25 mutant is blocked in saccharopine
reductase and suggested that pipecolic acid enters the lysine pathway
at the level of the
-aminoadipic acid-
-semialdehyde (Fig. 1).
|
Pipecolic acid is incorporated in the lysine pathway through its
conversion in P6C by the pipecolate oxidase.
The pipecolate
oxidase enzyme converts pipecolic acid into P6C which is the cyclic
form of the
-aminoadipic acid-
-semialdehyde.
-aminoadipic acid-
-semialdehyde) is
converted into saccharopine and lysine by the consecutive action of
saccharopine dehydrogenase and saccharopine reductase.
|
| |
DISCUSSION |
|---|
|
|
|---|
Pipecolic acid is formed by the catabolism of lysine in humans. Although this pathway is considered to be secondary in most tissues, pipecolic acid is the main lysine catabolism product in the brain (34, 35), and its accumulation was one of the first biochemical abnormalities detected in the Zellweger syndrome. In the filamentous fungi M. anisopliae and R. leguminicola, pipecolic acid, an intermediate in the biosynthesis of alkaloid compounds, comes directly from lysine catabolism, but through a different pathway than in mammals, involving the intermediates saccharopine and P6C (40-42).
As shown in this work, P. chrysogenum can use pipecolic acid through the action of pipecolate oxidase, thus converting pipecolic acid into P6C. Pipecolate oxidase has been shown to occur in the brain and liver of mammals, including humans (15, 30, 33, 35), and in Rhodotorula glutinis (26, 27), Pseudomonas putida (13), and Pseudomonas sp. (32).
In P. chrysogenum pipecolic acid can be converted into lysine, through its transformation into P6C, saccharopine, and finally lysine, by the consecutive action of pipecolate oxidase, saccharopine reductase, and saccharopine dehydrogenase (Fig. 1). It is unclear if the conversion of pipecolic acid into lysine is reversible in P. chrysogenum and whether pipecolic acid is synthesized from lysine catabolism (14, 20). Indeed, the reverse conversion of lysine into pipecolic acid through saccharopine and P6C corresponds exactly to the proposed pipecolic acid biosynthetic pathway in R. leguminicola (41, 42).
In this work we have cloned the lys7 gene encoding the
saccharopine reductase that is involved in the conversion of pipecolic acid to lysine. Saccharopine reductase (EC 1.5.1.10), also referred to
as saccharopine dehydrogenase (glutamate forming) or aminoadipic semialdehyde-glutamate reductase, catalyzes the penultimate step in the
lysine biosynthetic pathway by condensing the
-aminoadipic semialdehyde with the amino donor glutamic acid by a Schiff base mechanism in which the amino group of glutamic acid reacts with the
aldehyde group of the
-aminoadipic semialdehyde, resulting in the
formation of the pseudodipeptide saccharopine. Later,
saccharopine releases
-ketoglutarate, yielding lysine in the last
reaction of the lysine pathway catalyzed by saccharopine dehydrogenase.
The amino acid sequence of the protein encoded by lys7 of
P. chrysogenum is very similar to the sequences of the
saccharopine reductase from N. crassa, M. grisea
(24), S. cerevisiae (6), and
S. pombe. The C-terminal part of the protein is similar
(about 38% identity) to the C-terminal region (residues 400 to 800) of the lysine-
-ketoglutarate reductase/lysine dehydrogenase from several eukaryotic organisms such as Homo sapiens, Mus
musculus, and Arabidopsis thaliana, an enzyme with a
similar molecular mechanism to that of saccharopine reductase.
The saccharopine reductase from M. grisea has been purified and crystallized (24). Saccharopine reductase is a homodimer, and each subunit consists of three domains that are also present in the P. chrysogenum Lys7 protein. Domain I contains a variant of the Rossmann fold that binds NADPH. Domain II folds into a mixed seven-stranded beta-sheet flanked by alpha-helices and is involved in substrate binding and dimer formation. Domain III is all helical. The structure analysis of the ternary complex reveals a large movement of domain III upon ligand binding (25).
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a grant of the European Union, Brussels, Belgium (EUROFUNG II QLK3-1999-00729). L. Naranjo was supported by a MUTIS fellowship of the AECI (Ministry of Foreign Affairs, Madrid, Spain).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Area of Microbiology, Faculty of Biology and Environmental Sciences, University of León, 24071 León, Spain. Phone: 34 987 291505. Fax: 34 987 291506. E-mail: degjmm{at}unileon.es.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aharonowitz, Y., G. Cohen, and J. F. Martín. 1992. Penicillin and cephalosporin biosynthetic genes: structure, organization, regulation and evolution. Annu. Rev. Microbiol. 46:461-495[CrossRef][Medline]. |
| 2. |
Aspen, A. J., and A. Meister.
1962.
Conversion of -aminoadipic acid to L-pipecolic acid by Aspergillus nidulans.
Biochemistry
1:606-611[CrossRef][Medline].
|
| 3. | Bañuelos, O., J. Casqueiro, F. Fierro, M. J. Hijarrubia, S. Gutiérrez, and J. F. Martín. 1999. Characterization and lysine control of the expression of the lys1 gene encoding homocitrate synthase. Gene 226:51-59[CrossRef][Medline]. |
| 4. |
Bañuelos, O.,
J. Casqueiro,
S. Gutiérrez, and J. F. Martín.
2000.
Overexpression of the lys1 gene in Penicillium chrysogenum: homocitrate synthase levels, -aminoadipic acid pool and penicillin production.
Appl. Microbiol. Biotechnol.
54:69-77[CrossRef][Medline].
|
| 5. | Bañuelos, O., J. Casqueiro, S. Gutiérrez, J. Riaño, and J. F. Martín. 2000. The specific transport system for lysine is fully inhibited by ammonium in Penicillium chrysogenum: an ammonium-insensitive system allows uptake in carbon-starved cells. Antonie Leeuwenhoek 77:91-100. |
| 5a. | Bañuelos, O., J. Casqueiro, S. Steidl, S. Gutiérrez, A. Brakhage, and J. F. Martín. Subcellular localization of the homocitrate synthase in Penicillium chrysogenum. Mol. Gen. Genet., in press. |
| 6. |
Borrel, C. W.,
L. A. Urrestarazu, and J. K. Bhattacharjee.
1984.
Two unlinked lysine genes (LYS9 and LYS14) are required for the synthesis of saccharopine reductase in Saccharomyces cerevisiae.
J. Bacteriol.
159:429-432 |
| 7. | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-252[CrossRef][Medline]. |
| 8. | Cantoral, J. M., B. Díez, J. L. Barredo, E. Álvarez, and J. F. Martín. 1987. High frequency transformation of Penicillium chrysogenum. Bio/Technology 5:494-497[CrossRef]. |
| 9. |
Casqueiro, J.,
S. Gutiérrez,
O. Bañuelos,
F. Fierro,
J. Velasco, and J. F. Martín.
1998.
Characterization of the lys2 gene of Penicillium chrysogenum encoding -aminoadipic acid reductase.
Mol. Gen. Genet.
259:549-556[CrossRef][Medline].
|
| 10. | Casqueiro, J., O. Bañuelos, S. Gutiérrez, M. J. Hijarrubia, and J. F. Martín. 1999. Intrachromosomal recombination between direct repeats in Penicillium chrysogenum: gene conversion and deletion events. Mol. Gen. Genet. 261:994-1000[CrossRef][Medline]. |
| 11. |
Casqueiro, J.,
S. Gutiérrez,
O. Bañuelos,
M. J. Hijarrubia, and J. F. Martín.
1999.
Gene targeting in Penicillium chrysogenum: disruption of the lys2 gene leads to penicillin overproduction.
J. Bacteriol.
181:1181-1188 |
| 12. |
Casqueiro, J.,
O. Bañuelos,
S. Gutiérrez, and J. F. Martín.
2001.
Metabolic engineering of the lysine pathway for -lactam overproduction in Penicillium chrysogenum, p. 147-159.
In
A. Van Broedkhoven, J. Anné, and F. Shapiro (ed.), Focus on biotechnology, vol. 1. Novel frontiers in the production of compounds for biomedical use. Kluwer Academic Publishers, Dordrecht, The Netherlands.
|
| 13. | Chang, Y. F., and E. Adams. 1971. Induction of separate catabolic pathways for L- and D-lysine in Pseudomonas putida. Biochim. Biophys. Acta 45:570-576. |
| 14. |
Chang, Y. F.,
P. Ghosh, and V. V. Rao.
1990.
L-pipecolic acid metabolism in human liver: L- -aminoadipate- -semialdehyde oxidoreductase.
Biochim. Biophys. Acta
1038:300-305[CrossRef][Medline].
|
| 15. | Dodt, G., D. G. Kim, S. A. Reimann, B. Reuber, K. MacCabe, S. Gould, and S. Mihalik. 2000. L-pipecolic acid oxidase, a human enzyme essential for the degradation of L-pipecolic acid, is most similar to the monomeric sarcosine oxidases. Biochem. J. 345:487-494. |
| 16. |
Esmahan, C.,
E. Álvarez,
E. Montenegro, and J. F. Martín.
1994.
Catabolism of lysine in Penicillium chrysogenum leads to formation of -aminoadipic acid, a precursor of penicillin biosynthesis.
Appl. Environ. Microbiol.
60:1705-1710 |
| 17. |
Fangmeier, N., and E. Leistner.
1980.
A 15N NMR study on D-lysine metabolism in Neurospora crassa.
J. Biol. Chem.
255:10205-10209 |
| 18. |
Fierro, F.,
J. L. Barredo,
B. Díez,
S. Gutiérrez,
F. J. Fernández, and J. F. Martín.
1995.
The penicillin gene cluster is amplified in tandem repeats linked by conserved hexanucleotide sequences.
Proc. Natl. Acad. Sci. USA
92:6200-6204 |
| 19. | Fierro, F., K. Kosalková, S. Gutiérrez, and J. F. Martín. 1996. Autonomously replicating plasmids carrying the AMA1 region in Penicillium chrysogenum. Curr. Genet. 29:482-489[Medline]. |
| 20. |
Fothergill, J. C., and J. R. Guest.
1977.
Catabolism of L-lysine by Pseudomonas aeruginosa.
J. Gen. Microbiol.
99:139-155 |
| 21. |
Friedrich, G. C., and A. L. Demain.
1978.
Uptake and metabolism of -aminoadipate by Penicillium chrysogenum.
Arch. Microbiol.
119:43-47[CrossRef][Medline].
|
| 22. |
Hölinger, C., and C. P. Kubicek.
1989.
Regulation of the -(L- -aminoadipyl)-L-cysteinyl-D-valine and isopenicillin N biosynthesis in Penicillium chrysogenum by the -aminoadipate pool size.
FEMS Microbiol. Lett.
65:71-76.
|
| 23. |
Hölinger, C., and C. P. Kubicek.
1989.
Metabolism and compartmentation of -aminoadipic acid in penicillin-producing strains of Penicillium chrysogenum.
Biochim. Biophys. Acta
993:204-211.
|
| 24. | Johansson, E., J. J. Steffens, M. Emptage, Y. Lindqvist, and G. Schneider. 2000. Cloning, expression, purification and crystallization of saccharopine reductase from Magnaporthe grisea. Acta Crystallogr. D Biol. Crystallogr. 56:662-664[CrossRef][Medline]. |
| 25. | Johansson, E., J. J. Steffens, Y. Lindquist, and G. Schneider. 2000. Crystal structure of saccharopine reductase from Magnaporthe grisea, an enzyme of the alpha-aminoadipate pathway of lysine biosynthesis. Struct. Fold Des. 8:1037-1047[Medline]. |
| 26. |
Kinzel, J. J., and J. K. Bhattacharjee.
1982.
Lysine biosynthesis in Rhodotorula glutinis: properties of pipecolic acid oxidase.
J. Bacteriol.
151:1073-1077 |
| 27. |
Kurtz, M., and J. K. Bhattacharjee.
1975.
Biosynthesis of lysine in Rhodotorula glutinis: role of pipecolic acid.
J. Gen. Microbiol.
86:103-110 |
| 27a. |
Luengo, J. M.,
G. Revilla,
J. R. Villanueva, and J. F. Martín.
1980.
Inhibition and repression of homocitrate synthase by lysine in Penicillium chrysogenum.
J. Bacteriol.
144:869-876 |
| 28. | Martín, J. F., P. Liras, and J. R. Villanueva. 1974. Changes in composition of conidia of Penicillium notatum during germination. Arch. Microbiol. 97:39-50[CrossRef]. |
| 29. | Martín, J. F., S. Gutiérrez, and J. F. Aparicio. 2000. Secondary metabolites, p. 213-237. In J. Lederberg (ed.), Encyclopedia of microbiology, 2nd ed., vol. 4. Academic Press, San Diego, Calif. |
| 30. |
Mihalik, S. J.,
M. McGuiness, and P. A. Watkins.
1991.
Purification and characterization of perixosomal L-pipecolic acid oxidase from monkey liver.
J. Biol. Chem.
266:4822-4830 |
| 31. | Nielsen, J. B., M.-J. Hsu, K. M. Byrne, and L. Kaplan. 1991. Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation. Biochemistry 30:5789-5796[CrossRef][Medline]. |
| 32. |
Payton, C. W., and Y. F. Chang.
1982.
'-piperideine-2-carboxylate reductase of Pseudomonas putida.
J. Bacteriol.
149:864-871 |
| 33. | Rao, V. V., and Y. F. Chang. 1990. L-Pipecolic acid metabolism in human liver: detection of L-pipecolic oxidase and identification of its reaction product. Biochim. Biophys. Acta 1038:295-299[CrossRef][Medline]. |
| 34. | Rao, V. V., and Y. F. Chang. 1992. Assay for pipecolic acid oxidase activity in human liver: detection of enzyme deficiency in hyperpipecolic acidaemia. Biochim. Biophys. Acta 1139:189-195[Medline]. |
| 35. | Rao, V. V., M. J. Tsai, P. Xiaoming, and Y. F. Chang. 1993. L-pipecolic acid oxidation in rat: subcellular localization and developmental study. Biochim. Biophys. Acta 1164:29-35[CrossRef][Medline]. |
| 36. | Reynolds, K. A., and A. L. Demain. 1997. Rapamycin, FK506, and ascomycin-related compounds, p. 497-520. In W. R. Strohl (ed.), Bio/Technology of antibiotics. Marcel Dekker Inc., New York, N. Y. |
| 37. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 38. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 39. |
Shen, Y.,
V. Macino, and B. Birren.
1995.
Transformation of Escherichia coli with larger DNA molecules by electroporation.
Nucleic Acids Res.
23:1990-1996 |
| 40. | Sim, K. L., and D. Perry. 1997. Analysis of swainsonine and its early metabolic precursors in cultures of Metarhizium anisopliae. Glycoconjugate J. 14:661-668[CrossRef][Medline]. |
| 41. |
Wickwire, B. M.,
C. M. Harris,
T. M. Harris, and H. P. Broquist.
1990.
Pipecolic acid biosynthesis in Rhizoctonia leguminicola. I. The lysine, saccharopine 1-piperideine-6-carboxylic acid pathway.
J. Biol. Chem.
265:14742-14747 |
| 42. |
Wickwire, B. M.,
C. Wagner, and H. P. Broquist.
1990.
Pipecolic acid biosynthesis in Rhizoctonia leguminicola. II. Saccharopine oxidase: a unique flavine enzyme involved in pipecolic acid biosynthesis.
J. Biol. Chem.
265:14748-14753 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»